Myocardial Perfusion Imaging
12
0
0
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
8.3%
1 terminated out of 12 trials
90.0%
+3.5% vs benchmark
17%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (12)
Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis
Fractional Flow Reserve and Instantaneous Free-wave Ratio Revascularization Strategies in Women
Dotarem Evaluation for Myocardial Perfusion CMR
The Influence of Coronary Chronic Total Occlusion on Myocardial Perfusion on Computed Tomography
Real-Time Myocardial Perfusion Echocardiography in the ICU
Utility of Regadenoson Low-dose Dynamic Computed Tomography for Myocardial Perfusion Assesment (ULYSSES Study).
Myocardial Perfusion Imaging in Liver Transplantation Candidates
Regadenoson vs Dipyridamole in Use as Pharmacological Stress Agent Before SPECT
Meta-Analysis of Stress Myocardial Perfusion Imaging
Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging
Effect of Ranolazine on Myocardial Perfusion Assessed by Serial Quantitative Exercise SPECT Imaging
Myocardial Perfusion MRI